Alignment Healthcare Beats on Revenue but Cuts Full-Year 2026 Profit Outlook
ALHC sits 34% above its 52-week low of $6.01.
Summary
Alignment Healthcare grew Q3 revenue 36.7% to $1.36 billion but swung to an $8.1 million net loss as medical costs rose, and it lowered full-year 2026 adjusted EBITDA guidance to no less than $100 million.
Key Events · Earnings and Guidance · ALHC
-
Q3 Revenue Up 36.7%, Profit Turns Negative
Total revenue was $1,358.3 million versus $993.7 million a year earlier, but the company posted a net loss of $8.1 million compared with net income of $3.7 million in Q3 2025.
-
Medical Costs Pressure Margins
Adjusted gross profit rose 11.6% to $142.2 million while the medical benefits ratio climbed to 89.5%, up about 240 basis points year-over-year, on higher appeals and disputes, catastrophic cases and skilled nursing costs.
-
Full-Year Profit Guidance Cut
Full-year 2026 adjusted EBITDA guidance is now no less than $100 million and adjusted gross profit no less than $575 million, while membership guidance rose to 305,000 and revenue to $5,245 million.
-
Q4 Adjusted EBITDA Guided Negative
Fourth-quarter 2026 guidance calls for revenue of no less than $1,316 million, adjusted gross profit of no less than $104 million and adjusted EBITDA of no less than $(28) million.
Analysis · ALHC · Finance
Revenue growth is intact — $1.36 billion in Q3, up 36.7% — but medical costs ran hotter than planned, pushing the medical benefits ratio to 89.5% and turning a $3.7 million profit a year ago into an $8.1 million net loss. Management responded by cutting full-year adjusted EBITDA guidance to no less than $100 million and adjusted gross profit to no less than $575 million, even as it raised membership and revenue targets. The cut lands two weeks after the company's largest Medicare Advantage contract, California H3815 HMO, fell to 3.5 stars for 2027, so investors now face both a near-term margin problem and a longer-term quality-bonus risk.
How filings like this one have moved
In the 30 days to Nov 12, 2026, 47.3% of the 1873 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.17%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ALHC was trading at $8.03 on NASDAQ in the Finance sector, with a market capitalization of approximately $1.7B. The 52-week trading range was $6.01 to $25.12. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.